Cargando…
Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients
SIMPLE SUMMARY: Uveal melanoma (UM), patients with Class 1A gene expression profiling (GEP), have a lower metastatic risk (2% at 5 years) compared to Class 1B or Class 2 patients. However, further risk stratification could help to adapt follow-up intervals in Class 1A UM patients according to their...
Autores principales: | Ballhausen, Alexej, Urias, Elizabeth, Gruschkus, Stephen K., Williams, Michelle, Glover, Maura S., Qin, Yong, Gombos, Dan S., Patel, Sapna P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269154/ https://www.ncbi.nlm.nih.gov/pubmed/34209210 http://dx.doi.org/10.3390/cancers13133292 |
Ejemplares similares
-
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
por: Anand, Kartik, et al.
Publicado: (2019) -
Adjuvant Ipilimumab in High-Risk Uveal Melanoma
por: Fountain, Eric, et al.
Publicado: (2019) -
Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022) -
A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma
por: Mattei, Jane, et al.
Publicado: (2020) -
Tebentafusp: a first-in-class treatment for metastatic uveal
melanoma
por: Howlett, Sarah, et al.
Publicado: (2023)